Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Medimmune Llc — Human Necessities
Medimmune Llc holds 366 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Medimmune Llc |
| Technology | Human Necessities |
| Patents in slice | 366 |
| Recent patents in slice | 59 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Medimmune Llc to Human Necessities.
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Neutralizing anti-influenza A antibodies and uses thereof
US-12492240-B2 · Dec 9, 2025 · US
Recent filings
Latest patents from Medimmune Llc in Human Necessities.
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Bispecific PD-1 and TIGIT binding proteins and uses thereof
US-12570744-B2 · Mar 10, 2026 · US
Neutralizing anti-influenza A antibodies and uses thereof
US-12492240-B2 · Dec 9, 2025 · US
Related pages
Navigate to parent entity pages.